Partial Agonist and Biased Signaling Properties of the Synthetic Enantiomers J113863/UCB35625 at Chemokine Receptors CCR2 and CCR5.
about
Protein engineering of the chemokine CCL20 prevents psoriasiform dermatitis in an IL-23-dependent murine model.Biased signalling: from simple switches to allosteric microprocessors.Correspondence: Reply to 'Compound 17b and formyl peptide receptor biased agonism in relation to cardioprotective effects in ischaemia-reperfusion injury'.
P2860
Partial Agonist and Biased Signaling Properties of the Synthetic Enantiomers J113863/UCB35625 at Chemokine Receptors CCR2 and CCR5.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Partial Agonist and Biased Sig ...... okine Receptors CCR2 and CCR5.
@en
Partial Agonist and Biased Sig ...... okine Receptors CCR2 and CCR5.
@nl
type
label
Partial Agonist and Biased Sig ...... okine Receptors CCR2 and CCR5.
@en
Partial Agonist and Biased Sig ...... okine Receptors CCR2 and CCR5.
@nl
prefLabel
Partial Agonist and Biased Sig ...... okine Receptors CCR2 and CCR5.
@en
Partial Agonist and Biased Sig ...... okine Receptors CCR2 and CCR5.
@nl
P2093
P2860
P356
P1476
Partial Agonist and Biased Sig ...... okine Receptors CCR2 and CCR5.
@en
P2093
Alexandre Huszagh
Jean-Yves Springael
Jenny Corbisier
P2860
P304
P356
10.1074/JBC.M116.757559
P407
P577
2016-11-28T00:00:00Z